 Salarius Pharmaceuticals NASDAQ:SLRX and BioSpecifics Technologies NASDAQ:BSTC are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation. Insider and Institutional Ownership 5.7 of Salarius Pharmaceuticals shares are held by institutional investors. Comparatively, ... 